• Home
  • Study Details
Coming Soon

Medical Device Removing Excess Tissue in Digestive System in Individuals with Type 2 Diabetes on Insulin Therapy

The purpose of this research study is to learn more about the use of the Fractyl Revita System for the treatment of type 2 diabetes in patients who are on insulin therapy and certain other diabetes medications. The Revita System is a device that aids in removing excess tissue from the inner most layer of the small intestine, which is believed to play an important role in the control of type 2 diabetes. The procedure is expected to lead to an improvement in blood sugar control.

Age & Gender

  • 21 years ~ 70 years
  • Male, Female

Contact the Team


Thank you for your interest, but this study will start enrolling soon.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Nicholas Shaheen

Study Type

Clinical or Medical

Study Topics

Eating, Nutrition, and Metabolism
Wellness and Lifestyle
UNC or UNC Health employees

IRB Number




Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.


  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research